CloudMD Reaches Over 100,000 Registered Users on Telemedicine Platform

VANCOUVER, British Columbia, April 07, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH)(the “Company” or “CloudMD”), a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to announce that it has reached over 100,000 registered users combined on its CloudMD and MyHealthAccess telemedicine platforms. To date, CloudMD has grown its platform of registered users organically and a large part of its customer acquisition has come from referrals from its network of doctors in Canada. Patients on both platforms have easy access to the extended hours, 7-day week coverage provided by the CloudMD doctors.

Since its launch in February 2020, CloudMD has grown its platform by almost 10,000 app downloads. During the last two weeks, approximately 1000 virtual doctors' appointments were booked on the CloudMD platform, growth of over 3x compared to the previous period. Combined registration on both platforms has also increased 133% over the last week, as more people remain in isolation and cannot attend in-person medical appointments.

With the recent COVID-19 pandemic, CloudMD offers Canadians an alternative to in-person visits to crowded or closed medical clinics. Patients can now download the CloudMD app and schedule a same-day appointment online and connect directly with a licensed physician on their phone, tablet, or computer from the comfort of their home.

Dr. Essam Hamza, CEO of CloudMD commented,

“CloudMD continues to revolutionize the way healthcare is delivered to patients. We are excited and encouraged by the continued growth of our CloudMD platform as the significant increase in registered users continues to reinforce buy-in from the communities we serve.” He continued, “During these difficult times we are proud to offer much needed and timely medical care to the Canadian population. We remain committed to providing the best health care services to our patients.”

CloudMD also announces it has engaged Strike Communication Inc. (“Strike”) to manage investor relations and corporate development strategies. Strike is a boutique capital markets advisory firm based in Vancouver, BC. As part of its compensation, Strike will be granted incentive stock options exercisable to purchase up to 150,000 common shares in the capital of the Company at an exercise price of $0.50 per share for a period of five years. 100% of the incentive stock options will vest 12 months after the grant.

About CloudMD Software & Services

CloudMD Software & Services Inc. (CSE:DOC)(OTCQB:PHGRF)(Frankfurt: 6PH) is digitizing the delivery of healthcare by providing patients access to all points of their care from their phone, tablet or desktop computer. The Company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD currently provides service to a combined ecosystem of 315 clinics, over 3000 licensed practitioners and almost 3 million patient charts across its servers.

Forward Looking Statements

This news release contains forward-looking statements that are based on CloudMD’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans. Although CloudMD believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and CloudMD undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Please See Disclaimer

 


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of a third party, CloudMD Software & Services Inc. Market Jar Media Inc. expects to receive the following amounts from Native Ads Inc. in the amount of one hundred eight thousand and eight hundred CAD Dollars for 76 campaign days (54 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on StockStreetNews.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on StockStreetNews.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.